Results 181 to 190 of about 2,170,450 (367)

Parabiosis, Assembloids, Organoids (PAO)

open access: yesAdvanced Science, EarlyView.
This review evaluates parabiosis, organoids, and assembloids as complementary disease models spanning systemic, organ, and multi‐organ levels. It highlights their construction strategies, applications, and current limitations, while emphasizing their integration with frontier technologies such as artificial intelligence, organ‐on‐a‐chip, CRISPR, and ...
Yang Hong   +5 more
wiley   +1 more source

Renal Transplant in a Bardet–Biedl Syndrome Patient: A First Case From Azerbaijan

open access: yesCase Reports in Medicine
Rashad Sholan   +5 more
doaj   +1 more source

WCN24-1330 EFFECTS OF SGLT2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS ON TOP OF RAS BLOCKADE IN UNINEFRECTOMIZED DB/DB MICE

open access: yesKidney International Reports
María José Soler   +7 more
doaj   +1 more source

Physical Domains, Access to Kidney Transplantation, and Waitlist Mortality. [PDF]

open access: yesClin Transplant
Huang NS   +9 more
europepmc   +1 more source

Puerarin Targets MIC19 to Suppress Mitochondrial Metabolism of Tumor‐Infiltrating Tregs and Enhance Anti‐tumor Immunity

open access: yesAdvanced Science, EarlyView.
Puerarin targets mitochondrial MIC19 in tumor‐infiltrating Tregs, impairing their immunosuppressive function and enhancing antitumor immunity. This study uncovers the metabolic dependency of tumor‐infiltrating Tregs and highlights a potential metabolic‐targeted immunotherapeutic strategy for liver cancer. Abstract Regulatory T cells (Tregs) are pivotal
Yu Li   +10 more
wiley   +1 more source

Prevalence of Musculoskeletal and Metabolic Disorders in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis [PDF]

open access: gold
Álvaro Herreros-Carretero   +7 more
openalex   +1 more source

BSHI/BTS guidance on crossmatching before deceased donor kidney transplantation

open access: hybrid, 2021
Sarah Peacock   +29 more
openalex   +1 more source

Targeting the Notch1‐YY1‐ICAM1 Signaling Axis Enhances the Efficacy of Immunotherapy in HCC by Activating CD8+ T‐Cell‐Driven Cancer Cell Pyroptosis

open access: yesAdvanced Science, EarlyView.
In hepatocellular carcinoma (HCC), aberrantly activated Notch1 signaling induces its target gene YY1, which impairs immunotherapy efficacy by suppressing tumor cell‐ICAM1‐driven T cell activation and the mediated pyroptosis of T cells against tumor cells.
Ke Zhu   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy